Boutron I - Search Results

1

An education program for risk factor management after an acute coronary syndrome: a randomized clinical trial.

Cohen A, Assyag P, Boyer-Chatenet L, Cohen-Solal A, Perdrix C, Dalichampt M, Michel PL, Montalescot G, Ravaud P, Steg PG, Boutron I; Réseau Insuffisance Cardiaque (RESICARD) PREVENTION Investigators. Cohen A, et al. Among authors: boutron i. JAMA Intern Med. 2014 Jan;174(1):40-8. doi: 10.1001/jamainternmed.2013.11342. JAMA Intern Med. 2014. PMID: 24126705 Clinical Trial.

2

Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis.

Boutron I, Tubach F, Giraudeau B, Ravaud P. Boutron I, et al. JAMA. 2003 Aug 27;290(8):1062-70. doi: 10.1001/jama.290.8.1062. JAMA. 2003. PMID: 12941679

3

Premature application of trial results to clinical practice.

Boutron I, Ravaud P. Boutron I, et al. JAMA. 2003 Dec 17;290(23):3072; author reply 3072. doi: 10.1001/jama.290.23.3072-a. JAMA. 2003. PMID: 14679269 No abstract available.

4

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

Boutron I, Tubach F, Giraudeau B, Ravaud P. Boutron I, et al. J Clin Epidemiol. 2004 Jun;57(6):543-50. doi: 10.1016/j.jclinepi.2003.12.010. J Clin Epidemiol. 2004. PMID: 15246122

5

Inappropriateness of randomised trials for complex phenomena: single trial is never enough evidence to base decisions on.

Boutron I, Ravaud P, Giraudeau B. Boutron I, et al. BMJ. 2005 Jan 8;330(7482):94; author reply 95. doi: 10.1136/bmj.330.7482.94-a. BMJ. 2005. PMID: 15637381 Free PMC article. No abstract available.

6

Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases.

Baron G, Boutron I, Giraudeau B, Ravaud P. Baron G, et al. Among authors: boutron i. Arthritis Rheum. 2005 Jun;52(6):1858-65. doi: 10.1002/art.21116. Arthritis Rheum. 2005. PMID: 15934058 Free article.

7

Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease.

Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Ethgen M, et al. Among authors: boutron i. Ann Intern Med. 2005 Jul 5;143(1):20-5. doi: 10.7326/0003-4819-143-1-200507050-00006. Ann Intern Med. 2005. PMID: 15998751

8

Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism.

Thabut G, Estellat C, Boutron I, Samama CM, Ravaud P. Thabut G, et al. Among authors: boutron i. Eur Heart J. 2006 Jan;27(2):227-36. doi: 10.1093/eurheartj/ehi587. Epub 2005 Oct 13. Eur Heart J. 2006. PMID: 16223743 Review.

9

A review of blinding in randomized controlled trials found results inconsistent and questionable.

Boutron I, Estellat C, Ravaud P. Boutron I, et al. J Clin Epidemiol. 2005 Dec;58(12):1220-6. doi: 10.1016/j.jclinepi.2005.04.006. Epub 2005 Sep 30. J Clin Epidemiol. 2005. PMID: 16291465 Review.

10

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.

Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, Ravaud P. Boutron I, et al. J Clin Epidemiol. 2005 Dec;58(12):1233-40. doi: 10.1016/j.jclinepi.2005.05.004. Epub 2005 Oct 13. J Clin Epidemiol. 2005. PMID: 16291467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters